|
End-of-day quote
Taipei Exchange
04/09/2026
|
5-day change | 1st Jan Change | ||
| 22.10 TWD | -0.90% |
|
-2.86% | -14.17% |
| 08-13 | GlycoNex Incorporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 08-03 | GlycoNex Inc Doses First Patient In Phase I Trial Of GNX1021 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GLYCONEX INCORPORATION | Other Biotechnology & Medical Research | -0.90% | -2.86% | -14.17% | -16.29% | -21.07% | 79.08M |  |  | |
- Stock Market
- Stocks
- 4168 Stock
- Charts GlycoNex Incorporation
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
